Bionano Genomics
BNGO
BNGO
147 hedge funds and large institutions have $398M invested in Bionano Genomics in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
27% less capital invested
Capital invested by funds: $546M → $398M (-$148M)
Holders
147
Holding in Top 10
–
Calls
$38.3M
Puts
$18.5M
Top Buyers
| 1 | +$8.96M | |
| 2 | +$7.06M | |
| 3 | +$6.83M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$2.9M |
| 5 |
Squarepoint
New York
|
+$1.7M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$5.83M | |
| 3 | -$5.37M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.35M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$2.75M |